3% reported here The prevalence of EAH in ultra-MTBers (3 7%) an

3% reported here. The prevalence of EAH in ultra-MTBers (3.7%) and MTBers (7.1%) in the current study

was also similar to studies of multi-stage MTB races in South Africa and the Alps [21, 22], as well as single ultra-distance road cycling and MTB races in Switzerland [8, 25–28]. On average, post-race EAH in the Czech Republic amounted to 5.7% and did not exceed 10%. Regarding existing reports on EAH in single ultra-distance running races [1, 3, 4, 6–12, 38, 39], in MTB multi-stage races [21, 22], in single ultra-distance MTB races AZD1480 cell line [8, 22, 25, 28] the prevalence rates in the Czech Republic were no higher in the present athletes. An interesting finding was that the normonatremic group reported also symptoms typical for EAH. Muscle weakness, antidiuresis and breathing problems were the most reported post-race

symptoms Nutlin 3a in finishers in the 24-hour cycling races (R1, R2). Moreover, swelling and myalgia occurred in the multi-stage race alongside reported muscle weakness. The presented problems with antidiuresis could be associated with dehydration and SIADH (syndrome of inappropriate secretion of antidiuretic hormone). On the contrary, symptoms like chills, stomach pain and irritability in runners (R3) were probably more associated with race performance and were influenced by weather conditions. Post-race, all finishers, both hyponatremic and normonatremic, presented without symptoms of altered mental status. No subject required medical attention for hyponatremia. Regarding post-race symptoms associated with

race performance reported by finishers with EAH, the ultra-MTBer EAH-A-R2 reported muscle weakness. This symptom was frequent in all cycling races (R1,R2,R4). We assume that it could be related to higher race intensity during the races since EAH-A-R2 was also in the top finishers of the race Venetoclax ic50 and a more difficult racing terrain compared to the flat course in a 24-hour ultra-running event. Muscle weakness could be also associated with hypovolemia [52]. The myalgia reported in EAH-B-R3 and EAH-C-R4 may have been attributed to the extreme physical demands of the respective races, in all hyponatremic cases TTKG gradient increased and was > 10, presumably indicating an increased activity of aldosterone [2, 53]. We assume that athletes suffered a great stress. The swelling and antidiuresis in EAH-B-R3 and EAH-C-R4 may have been a result of fluid overload, thus further investigation is warranted. The consensus on EAH Elacridar concentration states that it left untreated, symptoms of EAH can digress rapidly [48], in the current study however, reported symptoms were left untreated in the aftermath of the races. Nonetheless, no severe symptomatic case of EAH encephalopathy associated with dehydration has been reported in literature [52]. Subjects EAH-A-R2, EAH-B-R3 and EAH-C-R4 were contacted 24 h and 72 h after their races.

Comments are closed.